Related Experiment Video

Updated: Jun 8, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

Published on: January 31, 2025

Imatinib treatment of generalized localized scleroderma (morphea)

Pia Moinzadeh, Thomas Krieg, Nicolas Hunzelmann

Journal of the American Academy of Dermatology

|October 19, 2010

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort.

Arthritis research & therapy·2026

Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD).

BMJ open respiratory research·2026

Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study.

The Lancet. Rheumatology·2026

Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosis.

Rheumatology (Oxford, England)·2026

Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon.

Rheumatology (Oxford, England)·2026

Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee.

Autoimmunity reviews·2026

See all related articles